Research articlePublished 20 Apr 2011
The Effects of 6β-Naltrexol, a Putative Neutral Opioid Antagonist, in Opioid-Dependent Subjects: A Proof-of-Concept Trial
1Addiction and Pharmacology Research Laboratory, California Pacific Medical Center Research Institute, San Francisco, CA, USA; 2Program in Pharmacogenomics, Department of Pharmacology, College of Medicine, The Ohio State University, Columbus OH, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Potential complications of prescription opioid use include abuse and constipation. 6β-Naltrexol (6βNTX), a neutral opioid antagonist, may alleviate these complications when co-formulated with μ-opioid analgesics. In a double-blind ascending dose study, four subjects on methadone maintenance received 6βNTX (0.05, 0.15, 0.50 and 1.0 mg). 6βNTX was generally well tolerated; three of four subjects reported willingness to take higher doses. Increased gastrointestinal activity was evidenced by decreased oral-cecal transit time and prompt laxation at higher doses.
Subjects
Mental Health and PsychologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Addiction Research & Therapy
- SubjectMental Health and Psychology
- BylineArticles whose byline prints “John Mendelson”
- BylineArticles whose byline prints “Linghui Li”
- BylineArticles whose byline prints “Keith Flower”
- BylineArticles whose byline prints “Will Harris”
- BylineArticles whose byline prints “Jeremy R Coyle”
- BylineArticles whose byline prints “C Y Angie Chen”
- BylineArticles whose byline prints “Wolfgang Sadee”
- BylineArticles whose byline prints “Gantt P Galloway”